MARC record from Internet Archive

LEADER: 03789cam 22006614a 4500
001 ocm45486186
003 OCoLC
005 20200424012300.0
008 021114s2000 ne a b 000 0 eng
010 $a 2003550407
040 $aDLC$beng$cDLC$dNLM$dUKM$dOHX$dVAM$dGSU$dBAKER$dNLGGC$dBTCTA$dYDXCP$dIG#$dCUN$dZWZ$dOCLCQ$dOCLCF$dOCLCO$dOCLCA
015 $aGBA074829$2bnb
016 7 $a101091121$2DNLM
016 7 $aB0017376$2bccb
020 $a0444500413$q(alk. paper)
020 $a9780444500410$q(alk. paper)
035 $a(OCoLC)45486186
042 $apcc
050 00 $aRM177$b.P576 2000
060 00 $a2001 D-422
060 10 $aWH 300$bP71775 2000
072 7 $aRB$2lcco
082 00 $a615/.39$222
245 00 $aPlatelet therapy :$bcurrent status and future trends /$cedited by Jerard Seghatchian, Edward L. Snyder, Pranee Krailadsiri.
250 $a1st ed.
260 $aAmsterdam ;$aNew York :$bElsevier,$c2000.
300 $axiii, 543 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references.
505 0 $aCh. 1. An overview of collection, processing, storage and quality monitoring of platelets -- Ch. 2. New perspective in manufacturing of platelets from the whole blood and apheresis -- Ch. 3. Platelet storage media -- Ch. 4. The effects of metabolic additives on platelet storage -- Ch. 5. Cold stored platelets -- Ch. 6. Frozen platelets -- Ch. 7. Lyophilized platelets for transfusion -- Ch. 8. Preservation of platelet function after cardiac surgery and apheresis -- Ch. 9. Biocompatibility assessment of filter materials -- Ch. 10. Cytoskeletal changes during platelet storage -- Ch. 11. Biological response modifiers in platelet transfusion therapy -- Ch. 12. Microvesicles in platelet concentrates -- Ch. 13. Platelet and residual leukocyte counting in platelet components.
505 0 $aCh. 14. Practical aspects of platelet storage lesion and quality -- Ch. 15. Thrombopoietin and Ex Vivo expansion of Megakaryocytes -- Ch. 16. Alternatives to platelet transfusion -- Ch. 17. Alternative strategies in platelet therapy -- Ch. 18. Bacterial contamination of platelets -- Ch. 19. Ultraviolet and gamma-irradiated platelets: In Vitro and In Vivo response -- Ch. 20. Inactivation of infectious pathogens and leukocytes in platelet concentrates -- Ch. 21. Trigger factors for prophylactic platelet transfusions -- Ch. 22. Strategies to provide effective platelets to patients refractory to random donor platelet support -- Ch. 23. Immunomodulatory aspects -- Ch. 24. Consensus Conference on Platelet Transfusion: Royal College of Physicians of Edinburgh.
650 0 $aBlood platelets$xTransfusion.
650 0 $aBlood platelets$xPreservation.
650 12 $aBlood Platelets.
650 22 $aBlood Preservation.
650 22 $aPlatelet Transfusion.
650 7 $aTransfusion plaquettes.$2fmesh
650 7 $aBlood platelets$xTransfusion.$2fast$0(OCoLC)fst00834790
700 1 $aSeghatchian, Jerard.
700 1 $aSnyder, Edward L.$q(Edward Leonard),$d1946-
700 1 $aKrailadsiri, Pranee.
938 $aBaker & Taylor$bBKTY$c249.00$d249.00$i0444500413$n0003623966$sactive
938 $aBaker and Taylor$bBTCP$n2003550407
938 $aOtto Harrassowitz$bHARR$nhar005141741
938 $aIngram$bINGR$n9780444500410
938 $aYBP Library Services$bYANK$n1718246
029 1 $aAU@$b000022100385
029 1 $aAU@$b000024983865
029 1 $aIG#$b9780444500410
029 1 $aNLM$b101091121
029 1 $aNZ1$b7994776
029 1 $aOHX$bhar005141741
029 1 $aYDXCP$b1718246
029 1 $aZWZ$b055707246
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 45 OTHER HOLDINGS